Toxicity of co-trimoxazole in nutritional haematinic deficiency.
D000741:Anemia, Aplastic / Q000139:chemically induced* / Q000188:drug therapy; D000748:Anemia, Macrocytic / Q000139:chemically induced; D001772:Blood Cell Count; D005492:Folic Acid / Q000627:therapeutic use; D005494:Folic Acid Deficiency / Q000628:therapy; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use; D009748:Nutrition Disorders / Q000150:complications*; D011704:Pyelonephritis / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000009:adverse effects*; D014295:Trimethoprim / Q000009:adverse effects*; D014508:Urea / Q000097:blood; D014805:Vitamin B 12 / Q000627:therapeutic use; D014806:Vitamin B 12 Deficiency / Q000628:therapy
D009268:Nalidixic Acid; D014508:Urea; D005492:Folic Acid; D014295:Trimethoprim; D007501:Iron; D013420:Sulfamethoxazole; D014805:Vitamin B 12